Buy Like Buffett
Watchlist

Flagship explainer

How TransMedics Group, Inc. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$605M · 100%Cost of revenue$243M · 40%Gross profit$363M · 60%Operating income$109M · 18%Income before tax$108M · 18%Income tax−$82.8M · −14%Net income$190M · 31%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$605M100%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-067032 · filed Feb 24, 2026
Cost of revenue$243M40%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-067032 · filed Feb 24, 2026
$363M60%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-067032 · filed Feb 24, 2026
$109M18%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-067032 · filed Feb 24, 2026
Income before tax$108M18%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-067032 · filed Feb 24, 2026
Income tax−$82.8M−14%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-067032 · filed Feb 24, 2026
$190M31%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-067032 · filed Feb 24, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-067032 · filed Feb 24, 2026
· event Dec 31, 2025 · retrieved Oct 17, 2026 · annual-row source set
Embed this chart

View the full TransMedics Group, Inc. analysis at Buy Like Buffett